Interacting Drugs |
Ketoconazole (systemic) vs Rivaroxaban |
Security Level |
|
Mechanism |
Rivaroxaban: P-glycoprotein/ABCB1 Inhibitors may increase the serum concentration of Rivaroxaban. |
Management |
Monitor therapy |
Ketoconazole (systemic) vs Rivaroxaban
Post Review about Ketoconazole (systemic) vs Rivaroxaban Click here to cancel reply.
Other Interactions of Ketoconazole (systemic)
Other Interactions of Rivaroxaban
Ketoconazole (systemic) vs Rivaroxaban
Interacting Drugs |
Ketoconazole (systemic) vs Rivaroxaban |
Security Level |
|
Mechanism |
Rivaroxaban: CYP3A4 Inhibitors (Strong) may increase the serum concentration of Rivaroxaban. |
Management |
Avoid combination |
No comments yet.
Post Review about Ketoconazole (systemic) vs Rivaroxaban Click here to cancel reply.
Other Interactions of Ketoconazole (systemic)
Other Interactions of Rivaroxaban
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.